Taisho Pharmaceutical Co., Ltd.

This study tests a new medicine called TS-172 for people on dialysis who have high phosphate levels. It will check if the drug is safe and works well over a long time. About 300 adults who already take phosphate binders will join.

This study tests an experimental drug called TS-172 in 30 adults with high phosphorus levels who are on peritoneal dialysis. The goal is to see if TS-172 can help bring phosphorus levels down to a safer range. Participants will take the drug and have regular blood tests to check …

This study tests a new medicine called TS-172 in 30 adults with high phosphate levels who are on hemodialysis (kidney machine) three times a week. The goal is to see if TS-172 can help bring phosphate levels down to a safer target. Participants will take the drug alongside their …

This study tests an experimental drug called TS-172 in 100 adults on hemodialysis who have high phosphorus levels (hyperphosphatemia). Participants continue their usual phosphate binders and are randomly assigned to receive TS-172 or a placebo. The main goal is to see if TS-172 h…

This study looks at how the drug TS-172 behaves in the body of people with mild or moderate liver impairment. Researchers will measure drug levels in the blood to understand how liver function affects the drug. The study involves 24 Japanese adults and is currently recruiting.